Scott D. Morenstein serves as Executive at Celator Pharmaceuticals Inc, where they oversee executive responsibilities. Since joining the company, Scott D. Morenstein has executed 10 insider transactions totaling $6.8M, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 21, 2019 involved purchasing 468,750 shares valued at $3.8M.
Scott D. Morenstein currently holds 2,052,991 shares of Celator Pharmaceuticals Inc (CNCE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott D. Morenstein has been a net buyer of CNCE stock. They have purchased $6.8M and sold $0 worth of shares.
Scott D. Morenstein's most recent insider trade was on Nov 21, 2019, when they purchased 468,750 shares at $8.00 per share.
Get notified when new Form 4 filings are submitted
| $5.50 |
| Discretionary |
| Jul 12, 2016 | CPXX | $31.4M | Tender | 1,039,109 | $30.25 | Discretionary |
| Jul 12, 2016 | CPXX | $189.9K | Disposition | 6,277 | $30.25 | Discretionary |
| Jan 1, 2016 | SNTA | $0 | Award | 17,857 | $N/A | Discretionary |
| Dec 3, 2015 | CPXX | $9.3K | Purchase | 5,000 | $1.87 | Discretionary |
| Feb 10, 2014 | CNCE | $0 | Other | 1,123,612 | $N/A | Discretionary |
| Feb 10, 2014 | CNCE | $0 | Other | 1,669,138 | $N/A | Discretionary |
| Feb 10, 2014 | CNCE | $0 | Other | 95,945 | $N/A | Discretionary |
| Feb 10, 2014 | CNCE | $0 | Other | 1,277 | $N/A | Discretionary |